News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
120 Results
Section
Business (18)
Deals (5)
Drug Development (25)
FDA (2)
News (48)
Tag
Approvals (2)
Cancer (1)
Clinical research (28)
Compensation (5)
Data (5)
Diabetes (6)
Earnings (17)
Events (39)
FDA (3)
GLP-1 (3)
Healthcare (1)
IPO (5)
Metabolic disorders (6)
Obesity (1)
People (6)
Phase I (12)
Phase II (17)
Pipeline (2)
Preclinical (8)
Regulatory (2)
Date
Last 30 days (2)
Last 365 days (31)
2025 (14)
2024 (30)
2023 (31)
2022 (32)
2021 (13)
Location
California (30)
Northern California (29)
United States (30)
120 Results for "biomeafusion".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 1, 2025
April 2, 2025
·
1 min read
Press Releases
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - March 3, 2025
March 4, 2025
·
1 min read
Press Releases
Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates
June 19, 2025
·
8 min read
Press Releases
Biomea Fusion Announces Leadership Transition
March 26, 2025
·
3 min read
Press Releases
Biomea Fusion Presents Updated Preliminary Clinical Data for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia at EHA 2025
June 16, 2025
·
7 min read
Press Releases
Biomea Fusion to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 6, 2025
·
1 min read
Press Releases
Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA)
June 23, 2025
·
10 min read
Press Releases
Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)
December 16, 2024
·
1 min read
Press Releases
Biomea Fusion Reports First Quarter 2025 Financial Results and Corporate Highlights
May 6, 2025
·
8 min read
Press Releases
Biomea Fusion’s BMF-500 Selected for Poster Presentation at EHA 2025 Highlighting Phase I Data in Relapsed/Refractory Acute Leukemia
May 14, 2025
·
8 min read
1 of 12
Next
